Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells

Por Loubière, Camille, Goiran, Thomas, Laurent, Kathiane, Djabari, Zied, Tanti, Jean-François, Bost, Frédéric
Publicado no Oncotarget (2015)

Metformin targets the GTPase Rac1 to inhibit prostate cancer cell migration

Por Dirat, Béatrice, Ader, Isabelle, Golzio, Muriel, Mettouchi, Amel, Laurent, Kathiane, Larbret, Frédéric, Malavaud, Bernard, Cormont, Mireille, Lemichez, Emmanuel, Tanti, Jean François, Bost, Frédéric
Publicado em 2014

Sirtuin 7: a new marker of aggressiveness in prostate cancer

Por Haider, Romain, Massa, Fabienne, Kaminski, Lisa, Clavel, Stephan, Djabari, Zied, Robert, Guillaume, Laurent, Kathiane, Michiels, Jean-François, Durand, Matthieu, Ricci, Jean-Ehrland, Tanti, Jean-François, Bost, Frédéric, Ambrosetti, Damien
Publicado no Oncotarget (2017)

The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells

Por Loubiere, Camille, Clavel, Stephan, Gilleron, Jerome, Harisseh, Rania, Fauconnier, Jeremy, Ben-Sahra, Issam, Kaminski, Lisa, Laurent, Kathiane, Herkenne, Stephanie, Lacas-Gervais, Sandra, Ambrosetti, Damien, Alcor, Damien, Rocchi, Stephane, Cormont, Mireille, Michiels, Jean-François, Mari, Bernard, Mazure, Nathalie M., Scorrano, Luca, Lacampagne, Alain, Gharib, Abdallah, Tanti, Jean-François, Bost, Frederic
Publicado no Sci Rep (2017)